Mandatum Life Insurance Co Ltd raised its stake in Clorox Company (The) (NYSE:CLX) by 38.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,624 shares of the company’s stock after buying an additional 2,400 shares during the period. Mandatum Life Insurance Co Ltd’s holdings in Clorox Company (The) were worth $1,138,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in shares of Clorox Company (The) by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after buying an additional 369,918 shares during the last quarter. Parnassus Investments CA grew its position in shares of Clorox Company (The) by 1.7% in the 3rd quarter. Parnassus Investments CA now owns 4,451,150 shares of the company’s stock valued at $587,151,000 after buying an additional 76,236 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Clorox Company (The) by 5.3% in the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after buying an additional 221,168 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Clorox Company (The) by 24.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after buying an additional 263,700 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of Clorox Company (The) by 24.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after buying an additional 265,200 shares during the last quarter. Hedge funds and other institutional investors own 72.74% of the company’s stock.

Clorox Company (CLX) traded down $0.20 during mid-day trading on Thursday, reaching $134.95. The company had a trading volume of 511,600 shares, compared to its average volume of 812,283. Clorox Company has a fifty-two week low of $112.28 and a fifty-two week high of $141.76. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. The firm has a market cap of $17,426.05, a P/E ratio of 24.35, a P/E/G ratio of 3.69 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the business earned $1.36 EPS. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. equities analysts predict that Clorox Company will post 5.58 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.49%. The ex-dividend date is Tuesday, January 23rd. Clorox Company (The)’s dividend payout ratio (DPR) is currently 61.88%.

A number of research analysts have recently issued reports on CLX shares. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. BMO Capital Markets set a $150.00 price objective on Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Barclays PLC reissued an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and an average price target of $128.72.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the transaction, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/11/23/mandatum-life-insurance-co-ltd-has-1-14-million-holdings-in-clorox-company-the-clx.html.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.